Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

KNC Laboratories Eyes Mass Production of Oligonucleotides for Nucleic Acid Drugs

Filed Under: Materials, Pharma Tagged With: , , , , , , ,

KNC Laboratories Co. Ltd. (TYO:6568) is moving to bolster its business in middle-molecule drugs. The company has developed a device…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Mitsui Chemicals to Re-Enter Nucleic Acid Drug CDMO Market
Mitsui Chemicals to Re-Enter Nucleic Acid Drug CDMO Market
NOF to Invest Big in DDS Materials in Anticipation of Growing Nucleic Acid Drug Market
NOF to Invest Big in DDS Materials in Anticipation of…
NOF Moves to Boost Production of DDS Materials for Biopharmaceuticals
NOF Moves to Boost Production of DDS Materials for…
Fujifilm Halves CO2 Emissions With Flow Synthesis Method
Fujifilm Halves CO2 Emissions With Flow Synthesis Method
Academic Research Group Develops Highly Efficient Method for Synthesizing Acrylic and Methacrylic Acid Esters
Academic Research Group Develops Highly Efficient Method for…
Sumitomo Chemical Eyes Mass Production of Nucleic Acid Drug Substance for Genome Editing
Sumitomo Chemical Eyes Mass Production of Nucleic Acid Drug…